MARCUS SCHABACKER

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Enveric Biosciences, Inc.

Filing Date Source Excerpt
2021-04-13 Marcus Schabacker
2022-05-31 Name Fees earned or paid in cash ($) Equity awards ($) Total ($) Marcus Schabacker 37,000 76,594 113,594 Consists of RSA’s equivalent to 15,957 shares of Common Stock, valued at $4.80 per share (the closing price per share on the date of the award). As of December 31, 2021, Marcus Schabacker had outstanding 15,957 RSA’s.

Data sourced from SEC filings. Last updated: 2026-02-03